PS
WVE icon

Principal Securities’s Wave Life Sciences WVE Stock Holding History

Principal Securities’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58
Closed -$425 – 3514
2025
Q3 		$425 Hold
58
– – ﹤0.01% 3566
2025
Q2 		$377 Hold
58
– – ﹤0.01% 3526
2025
Q1 		$717 Hold
58
– – ﹤0.01% 3285
2024
Q4 		$717 Buy
58
+13
+29% +$174 ﹤0.01% 3278
2024
Q3 		$369 Buy
45
+20
+80% +$120 ﹤0.01% 3317
2024
Q2 		$125 Buy
+25
New +$143 ﹤0.01% 3346

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Principal Securities's WVE Position: Q4 2025 in Review

Principal Securities sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 58 shares — an estimated $425 sold.

Principal Securities first reported a position in WVE in Q2 2024 and held it in 6 quarters. The position peaked at $717 in Q1 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Principal Securities reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 58 Wave Life Sciences shares in Q4 2025, an estimated $425.
  • Principal Securities first reported a position in Wave Life Sciences in Q2 2024 and held it in 6 quarters.
  • Principal Securities's Wave Life Sciences position peaked at $717 in Q1 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.